On this page
MedPlus Q1 profit falls 21% despite 22% revenue growth; shares drop 17%
Indian pharmacy retailer MedPlus reported Q1FY27 profit down 21.5% despite 21.8% revenue growth, as EBITDA margin contracted to 7.1%. Shares fell over 17%, while the company approved Rs 155 crore of capital expenditure in Hyderabad.
Reported figures
From the report. Source details below
| Q1FY27 consolidated net profit fell 21.5% YoY to Rs 33.2 crore from | Rs 42.3 crore |
|---|---|
| Revenue from operations rose 21.8% YoY to Rs 1,880 crore from | Rs 1,543 crore |
| EBITDA rose 2% YoY to Rs 133 crore from | Rs 131 crore |
| EBITDA margin narrowed to 7.1% from | 8.5% |
| Shares fell as much as 17.71% to | Rs 653 |
| Stock opened down 6.90% at | Rs 663.70 |
The source
First seen